Methods of using substituted tetralins and indanes
US7351857B2 · kind B2 · utility
1Cited by
4References
43Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 3, 2005 |
| Grant date | Apr 1, 2008 |
| Priority date | — |
| Expiry date | Aug 18, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features tetralin and indane compounds, compositions containing them, and methods of using them as PPAR alpha modulators to treat or inhibit the progression of, for example, diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.